Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Kansas Medical Center
About this trial
This is an ancillary laboratory study to collect and bank blood and tissue samples. The biospecimens collected for this study will be invaluable for future research into predictive biomarkers and genomic alterations and their correlation with clinical outcomes.
Eligibility criteria
Qualifiers
Ability of participant to understand this study, and participant willingness to sign a written informed consent. NOTE: Remote consenting allowed per IRB policy.
Stated willingness to comply with all study procedures and availability for the duration of the study
Males and/or females age ≥ 18 years
Advanced stage (IIIB to IV) non-small cell lung cancer (all types including mixed histology, without actionable mutations)
Disqualifiers
Diagnosed with a psychiatric illness or is in a social situation that would limit compliance with study requirements
Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation.
Advanced stage (IIIB to IV) non-small cell lung cancer with actionable mutations
Active viral infection (Hep C or B) requiring anti-viral therapy in the last 28 days. HIV patients on stable on anti-viral therapy able to receive therapy for the cancer are eligible to participate.
Trial design
Treatments tested in this trial
- Blood and Tissue Collection
Treatment groups
110 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov